In a real-world study, dose reductions of an FDA-approved therapy for pancreatic cancer were effective and associated with improved clinical outcomes in the treatment of advanced disease.
In a real-world study, dose reductions of an FDA-approved therapy for pancreatic cancer were effective and associated with improved clinical outcomes in the treatment of advanced disease.